{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:03:46Z","timestamp":1784253826409,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04983-6","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:04:48Z","timestamp":1779681888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between creatinine-to-cystatin C ratio and ALSFRS-R across clinical phenotypes"],"prefix":"10.1186","volume":"26","author":[{"given":"Yoshihisa","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Seno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Ohya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigo","family":"Yasutomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwako","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shugo","family":"Suwazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tokashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"4983_CR1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrneurol.2014.184","volume":"10","author":"B Swinnen","year":"2014","unstructured":"Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10:661\u201370.","journal-title":"Nat Rev Neurol"},{"key":"4983_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/21678421.2020.1779298","volume":"21","author":"C Bendotti","year":"2020","unstructured":"Bendotti C, Bonetto V, Pupillo E, Logroscino G, Al-Chalabi A, Lunetta C, et al. Focus on the heterogeneity of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:485\u201395.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4983_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13\u201321.","journal-title":"J Neurol Sci"},{"key":"4983_CR4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/acn3.51299","volume":"8","author":"QF Guo","year":"2021","unstructured":"Guo QF, Hu W, Xu LQ, Luo H, Wang N, Zhang QJ. Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2021;8:448\u201355.","journal-title":"Ann Clin Transl Neurol"},{"key":"4983_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/21678421.2019.1572192","volume":"20","author":"D Lanznaster","year":"2019","unstructured":"Lanznaster D, Bejan-Angoulvant T, Patin F, Andres CR, Vourc\u2019H P, Corcia P, et al. Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:199\u2013206.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4983_CR6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.7150\/ijbs.25711","volume":"14","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Yang M, Li F, Li M, Xu Z, Yang F, et al. Aberrant levels of cystatin C in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Int J Biol Sci. 2018;14:1041\u201353.","journal-title":"Int J Biol Sci"},{"key":"4983_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10072-023-06957-9","volume":"45","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Huo Y, Bai J, Li M, Wang H, Wang J, et al. Serum cystatin C is a potential biomarker for predicting amyotrophic lateral sclerosis survival. Neurol Sci. 2024;45:197\u2013201.","journal-title":"Neurol Sci"},{"key":"4983_CR8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/jcm10081582","volume":"10","author":"JE de la Rubia Ort\u00ed","year":"2021","unstructured":"de la Rubia Ort\u00ed JE, Armero JLP, Sanchis-Sanchis CE, Sancho-Castillo S, Salazar A, Caplliure-Llopis J, et al. Muscle function differences between patients with bulbar and spinal onset amyotrophic lateral sclerosis. Does it depend on peripheral glucose? J Clin Med. 2021;10:1582.","journal-title":"J Clin Med"},{"key":"4983_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/21678421.2014.990036","volume":"16","author":"H Watanabe","year":"2015","unstructured":"Watanabe H, Atsuta N, Nakamura R, Hirakawa A, Watanabe H, Ito M, et al. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:230\u20136.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4983_CR10","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.clnu.2019.10.027","volume":"39","author":"YL Lin","year":"2020","unstructured":"Lin YL, Chen SY, Lai YH, Wang CH, Kuo CH, Liou HH, et al. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease. Clin Nutr. 2020;39:2435\u201341.","journal-title":"Clin Nutr"},{"key":"4983_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12877-023-03784-7","volume":"23","author":"X Zhao","year":"2023","unstructured":"Zhao X, Su R, Hu R, Chen Y, Xu X, Yuan Y, et al. Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study. BMC Geriatr. 2023;23:89.","journal-title":"BMC Geriatr"},{"key":"4983_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/MNH.0000000000001022","volume":"33","author":"C Liu","year":"2024","unstructured":"Liu C, Levey AS, Ballew SH. Serum creatinine and serum cystatin C as an index of muscle mass in adults. Curr Opin Nephrol Hypertens. 2024;33:557\u201365.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"4983_CR13","first-page":"123","volume":"58","author":"A Gaiani","year":"2017","unstructured":"Gaiani A, Martinelli I, Bello L, Querin G, Puthenparampil M, Ruggero S, et al. Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in cerebrospinal fluid and serum. Neurobiol Aging. 2017;58:123\u201331.","journal-title":"Neurobiol Aging"},{"key":"4983_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ana.25276","volume":"84","author":"M Benatar","year":"2018","unstructured":"Benatar M, Wuu J, Andersen PM, Lombardi V, Malaspina A. Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion. Ann Neurol. 2018;84:130\u20139.","journal-title":"Ann Neurol"},{"key":"4983_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","volume":"90","author":"F Verde","year":"2019","unstructured":"Verde F, Steinacker P, Weishaupt JH, Kassubek J, Oeckl P, Halbgebauer S, et al. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90:157\u201364.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4983_CR16","doi-asserted-by":"publisher","first-page":"602663","DOI":"10.3389\/fneur.2021.602663","volume":"12","author":"LQ Xu","year":"2021","unstructured":"Xu LQ, Hu W, Guo QF, Xu GR, Wang N, Zhang QJ. Serum uric acid levels predict mortality risk in male amyotrophic lateral sclerosis patients. Front Neurol. 2021;12:602663.","journal-title":"Front Neurol"},{"key":"4983_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/21678421.2016.1214733","volume":"18","author":"\u00c9J O\u2019Reilly","year":"2017","unstructured":"O\u2019Reilly \u00c9J, Liu D, Johns DR, Cudkowicz ME, Paganoni S, Schwarzschild MA, et al. Serum urate at trial entry and ALS progression in EMPOWER. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:120\u20135.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"4983_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","volume":"66","author":"F Kimura","year":"2006","unstructured":"Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66:265\u20137.","journal-title":"Neurology"},{"key":"4983_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1212\/WNL.0000000000207223","volume":"101","author":"P Schito","year":"2023","unstructured":"Schito P, Russo T, Domi T, Mandelli A, Pozzi L, Del Carro U, et al. Clinical features and biomarkers to differentiate primary and amyotrophic lateral sclerosis in patients with an upper motor neuron syndrome. Neurology. 2023;101:352\u20136.","journal-title":"Neurology"},{"key":"4983_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/nan.12511","volume":"45","author":"B Gille","year":"2019","unstructured":"Gille B, De Schaepdryver M, Goossens J, Dedeene L, De Vocht J, Oldoni E, et al. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. Neuropathol Appl Neurobiol. 2019;45:291\u2013304.","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04983-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04983-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04983-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:25:43Z","timestamp":1784251543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04983-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4983"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04983-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8953813\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (2024) and current ethical guidelines, and was approved by the institutional hospital Ethics Review Board of NHO Okinawa Hospital (Approval No.2024-17). Written informed consent was not required because the study was retrospective, did not involve a clinical trial, and used anonymous data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"468"}}